Hiroaki Kitaoka
Overview
Explore the profile of Hiroaki Kitaoka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
168
Citations
1291
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amano M, Kitaoka H, Yoshikawa Y, Sakata Y, Dohi K, Tokita Y, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40088231
Background: To prevent sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM), the HCM Risk-SCD calculator and guideline recommendations are used to aid decision making for implantable cardioverter-defibrillator placement....
2.
Kawada K, Ishida T, Kubo T, Hamada T, Fukuda H, Hyohdoh Y, et al.
Geriatr Gerontol Int
. 2025 Mar;
PMID: 40066617
Aim: Rehospitalization of patients with heart failure (HF) incurs high health care costs and increased mortality. Infection-related rehospitalizations in patients with HF occur frequently, and the risk increases with age....
3.
Sugiura K, Kubo T, Inoue S, Nomura S, Yamada T, Tobita T, et al.
J Am Heart Assoc
. 2025 Mar;
:e038208.
PMID: 40055852
Background: Original apical hypertrophic cardiomyopathy was characterized by left ventricular hypertrophy confined to the apex below the papillary muscle level. In contrast, apical hypertrophic cardiomyopathy in Western countries often includes...
4.
Kubo T, Sugiura K, Tokita Y, Takano H, Takamisawa I, Takayama M, et al.
Heart
. 2025 Mar;
PMID: 40037766
Background: The Japanese Hypertrophic Cardiomyopathy Registry Study was designed to provide comprehensive, real-world insights into the clinical characteristics and management of hypertrophic cardiomyopathy (HCM) in Japan. Methods: This multicentre, prospective...
5.
Ochi Y, Kubo T, Yamasaki N, Baba Y, Kitaoka H
CASE (Phila)
. 2025 Mar;
9(1):4-8.
PMID: 40027905
No abstract available.
6.
Ishida T, Kawada K, Jobu K, Hamada T, Kubo T, Okazaki M, et al.
Front Cardiovasc Med
. 2025 Jan;
11:1470216.
PMID: 39877026
Background: Constipation frequently affects heart failure patients because of medication side effects and physiological effects of the condition. Although recent speculation suggests that comorbid constipation may affect cardiovascular disease onset...
7.
Nishimura T, Ochi Y, Arima N, Sugiura K, Hirota T, Kubo T, et al.
J Cardiol Cases
. 2025 Jan;
31(1):20-23.
PMID: 39839739
Learning Objectives: •In the case of worsening heart failure in patients who have undergone left atrial (LA) catheter ablation, the possibility of stiff LA syndrome due to calcification of the...
8.
Nakaya Y, Akamatsu M, Yakushiji K, Ogimoto A, Kitaoka H
Int Heart J
. 2025 Jan;
66(1):66-73.
PMID: 39828339
Cardiac rehabilitation (CR) improves physical function in patients with acute decompensated heart failure (ADHF) and frailty. However, few studies have assessed physical function through multiple measures during hospitalization; moreover, the...
9.
Baba Y, Kubo T, Nabeta T, Matsue Y, Kitai T, Naruse Y, et al.
ESC Heart Fail
. 2024 Dec;
PMID: 39731226
Aims: The prognostic role of high-sensitivity cardiac troponin T (hs-cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B-type...
10.
Ochi Y, Kubo T, Baba Y, Miyagawa K, Noguchi T, Hirota T, et al.
J Cardiol
. 2024 Dec;
PMID: 39631695
No abstract available.